Gene · 409
Papers2,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution. | Sci Rep | 2022 | 35688965 | PubTator, text mining | PubMed |
| The CXCL12/CXCR4/ACKR3 Signaling Axis Regulates PKM2 and Glycolysis. | Cells | 2022 | 35681470 | PubTator, text mining | PubMed |
| A systematic review of translation and experimental studies on internal anal sphincter for fecal incontinence. | Ann Coloproctol | 2022 | 35678021 | PubTator, text mining | PubMed |
| The reduced serum concentrations of β-arrestin-1 and β-arrestin-2 in pregnancies complicated with gestational diabetes mellitus. | J Matern Fetal Neonatal Med | 2022 | 35674413 | PubTator, text mining | PubMed |
| A Small-Molecule Oral Agonist of the Human Glucagon-like Peptide-1 Receptor. | J Med Chem | 2022 | 35647711 | PubTator, text mining | PubMed |
| Role of MrgprB2 in Rosacea-Like Inflammation in Mice: Modulation by β-Arrestin 2. | J Invest Dermatol | 2022 | 35644498 | PubTator, text mining | PubMed |
| The Molecular Genetics of Dissociative Symptomatology: A Transdiagnostic Literature Review. | Genes (Basel) | 2022 | 35627228 | PubTator, text mining | PubMed |
| Central and Peripheral Immune Dysregulation in Posttraumatic Stress Disorder: Convergent Multi-Omics Evidence. | Biomedicines | 2022 | 35625844 | PubTator, text mining | PubMed |
| PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference. | Hepatology | 2022 | 35603482 | PubTator, text mining | PubMed |
| Serodolin, a β-arrestin-biased ligand of 5-HT7 receptor, attenuates pain-related behaviors. | Proc Natl Acad Sci U S A | 2022 | 35594393 | PubTator, text mining | PubMed |
Mechanical Activation of the β2-Adrenergic Receptor by Meningococcus: A Historical and Future Perspective Analysis of How a Bacterial Probe Can Reveal Signalling Pathways in Endothelial Cells, and a Unique Mode of Receptor Activation Involving Its N-Terminal Glycan Chains. | Front Endocrinol (Lausanne) | 2022 | 35586623 | PubTator, text mining | PubMed |
| Sustained endosomal release of a neurokinin-1 receptor antagonist from nanostars provides long-lasting relief of chronic pain. | Biomaterials | 2022 | 35533442 | PubTator, text mining | PubMed |
| Prediction of the Immune Phenotypes of Bladder Cancer Patients for Precision Oncology. | IEEE Open J Eng Med Biol | 2022 | 35519421 | PubTator, text mining | PubMed |
| Signature transcriptome analysis of stage specific atherosclerotic plaques of patients. | BMC Med Genomics | 2022 | 35488341 | PubTator, text mining | PubMed |
| GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision. | Cell | 2022 | 35483373 | PubTator, text mining | PubMed |
| Pharmacological evaluation and forensic case series of N-pyrrolidino etonitazene (etonitazepyne), a newly emerging 2-benzylbenzimidazole 'nitazene' synthetic opioid. | Arch Toxicol | 2022 | 35477798 | PubTator, text mining | PubMed |
| G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions and inflammation. | Cell Signal | 2022 | 35461901 | PubTator, text mining | PubMed |
| First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass. | Arch Toxicol | 2022 | 35449307 | PubTator, text mining | PubMed |
| Integrative analysis of key microRNA-mRNA complexes and pathways in aortic aneurysm. | Ann Transl Med | 2022 | 35433971 | PubTator, text mining | PubMed |
| Double life: How GRK2 and β-arrestin signaling participate in diseases. | Cell Signal | 2022 | 35430346 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/409/papers?page=19